Literature DB >> 14502113

When to conduct testing in patients with suspected irritable bowel syndrome.

Nicholas J Talley1.   

Abstract

Patients who have abdominal discomfort or pain plus disturbed defecation warrant a careful history taking and physical examination. The presence of positive symptom criteria for irritable bowel syndrome (IBS) usually correctly identifies the underlying IBS diagnosis. The clinical evaluation may uncover findings that cause concern about underlying organic disease ("alarm features" or "red flags"). Traditional alarm features include bleeding, obvious anemia, weight loss, and older age at onset. Although the diagnostic utility of most of these red flags has not been tested, patients with these symptoms should be investigated promptly. In the primary care setting, most patients who have alarm symptoms will have a negative further evaluation, and the original IBS diagnosis will be confirmed. In the past, numerous tests (eg, complete blood cell count, flexible sigmoidoscopy) were considered routine for patients with suspected IBS in the primary care setting. However, available data do not support this approach; these patients do not have an increased likelihood of most organic diseases compared with control populations without IBS. Although celiac disease may occur more frequently in persons with IBS, the yield of serologic testing is likely to be low. Testing is generally not required in patients with positive symptom criteria for IBS and an absence of alarm features.

Entities:  

Mesh:

Year:  2003        PMID: 14502113

Source DB:  PubMed          Journal:  Rev Gastroenterol Disord        ISSN: 1533-001X


  4 in total

Review 1.  IBS--review and what's new.

Authors:  Amy Foxx-Orenstein
Journal:  MedGenMed       Date:  2006-07-26

2.  New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.

Authors:  Mark Pimentel; Laura Hwang; Gil Y Melmed; Kimberly Low; Eric Vasiliauskas; Andrew Ippoliti; Janet Yang; Sheila Lezcano; Jeffrey L Conklin; Ara Sahakian
Journal:  Dig Dis Sci       Date:  2009-01-24       Impact factor: 3.199

3.  Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary care.

Authors:  Åshild Faresjö; Ewa Grodzinsky; Claes Hallert; Toomas Timpka
Journal:  BMC Public Health       Date:  2013-09-11       Impact factor: 3.295

4.  Psychosocial factors at work and in every day life are associated with irritable bowel syndrome.

Authors:  Ashild Faresjö; Ewa Grodzinsky; Saga Johansson; Mari-Ann Wallander; Toomas Timpka; Ingemar Akerlind
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 12.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.